Xuchang KETOP Testing Research Institute Co.,Ltd (SHE:003008)
China · Delayed Price · Currency is CNY 24.15
-0.11 (-0.45%)
At close: Feb 13, 2026
SHE:003008 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 220.38 | 220.1 | 189.62 | 154.93 | 142.79 | 164.41 |
Other Revenue | 1.24 | 1.24 | 1.21 | 1.05 | 1.11 | 1.07 |
| 221.62 | 221.34 | 190.83 | 155.98 | 143.9 | 165.49 | |
Revenue Growth (YoY) | -0.01% | 15.99% | 22.34% | 8.40% | -13.05% | -18.42% |
Cost of Revenue | 76.62 | 74.41 | 65.51 | 47.87 | 46.03 | 50.98 |
Gross Profit | 145 | 146.93 | 125.32 | 108.11 | 97.87 | 114.51 |
Selling, General & Admin | 45.59 | 44.43 | 45.19 | 31.79 | 27.86 | 25.46 |
Research & Development | 12.71 | 11.2 | 11.78 | 10.6 | 10.02 | 9.17 |
Other Operating Expenses | 6.22 | 5.04 | 4.74 | 2.55 | 2.44 | 2.51 |
Operating Expenses | 65.1 | 60.76 | 62.48 | 45.09 | 40.37 | 37.48 |
Operating Income | 79.9 | 86.17 | 62.83 | 63.02 | 57.49 | 77.02 |
Interest Expense | -0.02 | -0.03 | -0.03 | -0.04 | -0.02 | - |
Interest & Investment Income | 15.7 | 16.94 | 14.84 | 17.13 | 15.46 | 3.08 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0 | -0.01 | - | -0 |
Other Non Operating Income (Expenses) | 0.29 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
EBT Excluding Unusual Items | 95.86 | 103.05 | 77.62 | 80.09 | 72.92 | 80.08 |
Gain (Loss) on Sale of Investments | -1.58 | -0.46 | 0.3 | -0.43 | 0.4 | 0.85 |
Gain (Loss) on Sale of Assets | - | - | - | 0 | - | - |
Asset Writedown | -0.39 | -0.37 | -0.11 | -0.03 | -0.25 | - |
Other Unusual Items | -0.74 | 1.17 | 6.86 | 1.39 | 2.18 | 5.02 |
Pretax Income | 93.16 | 103.39 | 84.66 | 81.03 | 75.25 | 85.95 |
Income Tax Expense | 5.73 | 17.84 | 25.87 | 12.02 | 11 | 11.69 |
Net Income | 87.42 | 85.56 | 58.79 | 69.01 | 64.25 | 74.26 |
Net Income to Common | 87.42 | 85.56 | 58.79 | 69.01 | 64.25 | 74.26 |
Net Income Growth | 28.63% | 45.52% | -14.81% | 7.40% | -13.48% | -31.38% |
Shares Outstanding (Basic) | 104 | 104 | 103 | 104 | 104 | 85 |
Shares Outstanding (Diluted) | 104 | 104 | 103 | 104 | 104 | 85 |
Shares Change (YoY) | 1.15% | 1.16% | -1.13% | -0.08% | 23.29% | 8.35% |
EPS (Basic) | 0.84 | 0.82 | 0.57 | 0.66 | 0.62 | 0.88 |
EPS (Diluted) | 0.84 | 0.82 | 0.57 | 0.66 | 0.62 | 0.88 |
EPS Growth | 27.17% | 43.86% | -13.83% | 7.49% | -29.82% | -36.67% |
Free Cash Flow | 88.03 | 70.01 | 59.42 | 10.13 | 2.22 | 52.32 |
Free Cash Flow Per Share | 0.85 | 0.67 | 0.58 | 0.10 | 0.02 | 0.62 |
Dividend Per Share | 1.000 | 1.000 | 0.231 | 0.385 | 0.385 | 0.462 |
Dividend Growth | 36.84% | 333.28% | -39.99% | - | -16.66% | - |
Gross Margin | 65.43% | 66.38% | 65.67% | 69.31% | 68.01% | 69.19% |
Operating Margin | 36.05% | 38.93% | 32.93% | 40.40% | 39.95% | 46.54% |
Profit Margin | 39.45% | 38.65% | 30.81% | 44.24% | 44.65% | 44.87% |
Free Cash Flow Margin | 39.72% | 31.63% | 31.14% | 6.49% | 1.54% | 31.62% |
EBITDA | 130.01 | 138.7 | 118.59 | 101.06 | 89.56 | 108.29 |
EBITDA Margin | 58.66% | 62.66% | 62.14% | 64.79% | 62.24% | 65.44% |
D&A For EBITDA | 50.11 | 52.53 | 55.75 | 38.04 | 32.06 | 31.27 |
EBIT | 79.9 | 86.17 | 62.83 | 63.02 | 57.49 | 77.02 |
EBIT Margin | 36.05% | 38.93% | 32.93% | 40.40% | 39.95% | 46.54% |
Effective Tax Rate | 6.16% | 17.25% | 30.56% | 14.83% | 14.61% | 13.60% |
Revenue as Reported | 221.62 | 221.34 | 190.83 | 155.98 | 143.9 | 165.49 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.